|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
c.-676T>A |
- |
- |
0.00648824 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.32 |
- |
- |
- |
0.32 |
- |
BRCA1_00636 |
1 |
c.-19-10T>C |
IVS1-10T>C |
- |
0.01599425 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
0.0626 |
- |
0.2383744 |
2.114449539 |
- |
0.031552318 |
- |
BRCA1_00626 |
1 |
c.-19-5T>C |
IVS1-5T>C |
- |
0.186313842 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.430243382 |
1.033092037 |
- |
0.444481012 |
- |
BRCA1_00273 |
1 |
c.-19-3A>G |
IVS1-3A>G |
- |
0.000863879 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
1 |
- |
- |
2.6741E-05 |
0.000026741 |
- |
BRCA1_00272 |
2 |
c.-14T>C |
5'UTR106T>C |
- |
0.245376397 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
15.42266644 |
1.033092037 |
- |
15.93303389 |
- |
BRCA1_00238 |
2 |
c.1A>G |
120A>G |
p.M1V |
0.985491446 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
1.27139304 |
2.226064 |
- |
- |
- |
2.830202277 |
- |
BRCA1_00279 |
2 |
c.3G>T |
122G>T |
p.M1I |
0.994371232 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
1.9734 |
3.73 |
- |
- |
- |
7.360782 |
- |
BRCA1_00428 |
2 |
c.10T>C |
129T>C |
p.S4P |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.0367 |
0.49 |
- |
- |
- |
0.507983 |
- |
BRCA1_00204 |
2 |
c.19C>G |
138C>G |
p.R7G |
0.002998405 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
0.2431 |
0.4 |
- |
- |
- |
0.09724 |
- |
BRCA1_00277 |
2 |
c.19C>T |
138C>T |
p.R7C |
- |
- |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
1.0368 |
- |
0.704096958 |
1.526888007 |
- |
1.114640041 |
- |
BRCA1_00278 |
2 |
c.43A>C |
162A>C |
p.I15L |
0.002026338 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.3304 |
0.180213076 |
1.102597599 |
- |
0.065651308 |
- |
BRCA1_00475 |
2 |
c.53T>C (Reported 2 times) |
172T>C |
p.M18T |
0.9840 |
4 - Likely pathogenic |
Easton et al. 2007 (PMID17924331) |
Tavtigian et al. 2008 |
0.66 |
0.01 |
0.00 |
0.66 |
1 |
- |
25.7 |
1.23 |
- |
31.611 |
- |
BRCA1_00040 |
2 |
c.65T>C |
184T>C |
p.L22S |
0.9940 |
5 - Definitely pathogenic |
Easton et al 2007 (PMID17924331), Sweet et al. 2010 (PMID9543972) |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
- |
38.88 |
- |
- |
38.88 |
- |
BRCA1_00111 |
2 |
c.80+1G>A |
IVS2+1G>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
0.414387178 |
1.244651749 |
- |
0.515767726 |
- |
BRCA1_00480 |
2 |
c.80+1G>C |
IVS2+1G>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
0.9952 |
- |
0.641810162 |
1.033092037 |
- |
0.659866333 |
- |
BRCA1_00646 |
2 |
c.80+1G>T |
IVS2+1G>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
1.476165189 |
1.049836689 |
- |
1.549732374 |
- |
BRCA1_00647 |
2 |
c.80+3A>C |
IVS2+3A>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
1.9975 |
- |
- |
- |
- |
1.9975 |
- |
BRCA1_00648 |
2 |
c.80+5G>A |
IVS2+5G>A |
- |
0.968819908 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
15.0547 |
1.492 |
2.599266094 |
1.033092037 |
- |
60.31574334 |
- |
BRCA1_00483 |
2 |
c.81-65G>C |
IVS2-65G>C |
- |
2.45529E-08 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.25119808 |
4.78942E-06 |
- |
- |
1.46535E-07 |
0.00000120309 |
- |
BRCA1_00711 |
2 |
c.81-14C>A |
IVS2-14C>A |
- |
0.522346036 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
1.988986826 |
1.067279157 |
- |
2.122804183 |
- |
BRCA1_00654 |
2 |
c.81-14C>T |
IVS2-14C>T |
- |
1.76047E-08 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
0.00012452 |
0.003393123 |
- |
- |
- |
0.000000422513 |
- |
BRCA1_00710 |
2 |
c.81-13C>A |
IVS2-13C>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.404225807 |
1.297514181 |
- |
0.524488717 |
- |
BRCA1_00709 |
2 |
c.81-12del |
IVS2-12delC |
- |
0.003464969 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
0.080775381 |
1.033092037 |
- |
0.083448403 |
- |
BRCA1_00708 |
2 |
c.81-12dup |
IVS2-12insC |
- |
0.018322005 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
0.419698235 |
1.067279157 |
- |
0.447935179 |
- |
BRCA1_00652 |
2 |
c.81-9C>G |
IVS2-9C>G |
- |
0.99644674 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
8.126408294 |
1.067279157 |
- |
8.673146196 |
- |
BRCA1_00484 |
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
2 |
c.81-6T>C |
IVS2-6T>C |
- |
0.069824614 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
0.32 |
0.298230158 |
1.526888007 |
- |
0.145716496 |
- |
BRCA1_00712 |
3 |
c.81-13C>G |
IVS2-13C>G |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.34 |
0.00 |
0.34 |
1 |
- |
0.07 |
0.01 |
- |
8.51E-04 |
- |
BRCA1_00133 |
3 |
c.81-11delT |
IVS2-11delT |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.34 |
0.00 |
0.34 |
1 |
- |
0.03 |
4.07E-03 |
- |
1.32E-04 |
- |
BRCA1_00132 |
3 |
c.81T>C |
200T>C |
p.C27C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
- |
- |
0.700020165 |
1.067279157 |
- |
0.747116932 |
- |
BRCA1_00660 |
3 |
c.83T>C |
202T>C |
p.L28P |
0.635896419 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.81 |
0.04 |
0.02 |
0.81 |
- |
- |
0.383841549 |
1.067279157 |
- |
0.409666085 |
- |
BRCA1_00664 |
3 |
c.97G>C |
216G>C |
p.E33Q |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.599508314 |
1.067279157 |
- |
0.639842728 |
- |
BRCA1_00674 |
3 |
c.110C>A |
229C>A |
p.T37K |
0.9996 |
5 - Definitely pathogenic |
Sweet et al., 2010 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
8.73 |
72.68 |
- |
- |
634.496 |
- |
BRCA1_00112 |
3 |
c.115T>C |
234T>C |
p.C39R |
0.9933 |
5 - Definitely pathogenic |
Sweet et al., 2010 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
3.586 |
9.65 |
- |
- |
34.6049 |
- |
BRCA1_00113 |
3 |
c.121C>T |
240C>T |
p.H41Y |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
1.6597 |
- |
- |
- |
- |
1.6597 |
- |
BRCA1_00209 |
3 |
c.122A>G |
241A>G |
p.H41R |
0.995 |
5 - Definitely pathogenic |
Whiley et al., 2014 |
Tavtigian et al. 2008 |
0.29 |
0.02 |
0.00 |
0.29 |
159.17 |
2.95 |
- |
- |
- |
469.55 |
- |
BRCA1_00130 |
3 |
c.130T>A |
249T>A |
p.C44S |
0.9984 |
5 - Definitely pathogenic |
Sweet et al., 2010 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
- |
149.6 |
- |
- |
149.6 |
- |
BRCA1_00115 |
3 |
c.131G>A |
250G>A |
p.C44Y |
0.9972 |
5 - Definitely pathogenic |
Sweet et al., 2010 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
2.95 |
28.25 |
- |
- |
83.3375 |
- |
BRCA1_00114 |
3 |
c.131G>T |
250G>T |
p.C44F |
0.999963582 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
156.1745 |
41.240528 |
- |
- |
- |
6440.71884 |
- |
BRCA1_00217 |
3 |
c.133A>C |
252A>C |
p.K45Q |
0.00080 |
1 - Not pathogenic or of no clinical significance |
Sweet et al., 2010 |
Tavtigian et al. 2008 |
0.03 |
0.04 |
0.00 |
0.03 |
- |
0.0193 |
1.344 |
- |
- |
0.02594 |
- |
BRCA1_00116 |
3 |
c.134A>C |
253A>C |
p.K45T |
0.001772917 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
0.04 |
0.02 |
0.04 |
- |
- |
0.038659242 |
1.102597599 |
- |
0.042625587 |
- |
BRCA1_00221 |
3 |
c.134+5G>A |
IVS3+5G>A |
- |
0.5804184 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
2.599266094 |
1.033092037 |
- |
2.685281104 |
- |
BRCA1_00219 |
3 |
c.134+5G>T |
IVS3+5G>T |
- |
0.1490459 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
0.34 |
- |
- |
- |
0.34 |
- |
BRCA1_00289 |
3 |
c.135-20T>G |
IVS4-20T>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.914806725 |
1.033092037 |
- |
0.945079543 |
- |
BRCA1_00225 |
3 |
c.135-18T>G |
IVS4-18T>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.641810162 |
1.067279157 |
- |
0.684990609 |
- |
BRCA1_00293 |
3 |
c.135-1G>T |
IVS4-1G>T |
- |
0.999998384 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
9528 |
2.008856151 |
- |
- |
- |
19140.3814 |
- |
BRCA1_00294 |
5 |
c.135-?_441+?dup |
Exon 5-7dup |
- |
0.876576367 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
0.1772 |
1.67 |
- |
- |
- |
0.295924 |
- |
BRCA1_00222 |
5 |
c.140G>A |
259G>A |
p.C47Y |
0.999999713 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
13545 |
60.31 |
- |
- |
- |
816898.95 |
- |
BRCA1_00231 |
5 |
c.154C>A |
273C>A |
p.L52I |
0.004114034 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.125149957 |
1.067279157 |
- |
0.133569941 |
- |
BRCA1_00243 |
5 |
c.154C>T |
273C>T |
p.L52F |
0.125674152 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
- |
- |
0.215947303 |
1.629615745 |
- |
0.351911125 |
- |
BRCA1_00244 |
5 |
c.172C>A |
291C>A |
p.P58T |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
1.389376475 |
1.033092037 |
- |
1.435353773 |
- |
BRCA1_00252 |
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
5 |
c.172C>G |
291C>G |
p.P58A |
0.014928405 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.49 |
- |
- |
- |
0.49 |
- |
BRCA1_00253 |
5 |
c.179A>G |
298A>G |
p.Q60R |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
1.15 |
- |
- |
- |
1.15 |
- |
BRCA1_00261 |
5 |
c.181T>A |
300T>A |
p.C61G |
0.956784356 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
1.3923 |
3.73 |
- |
- |
- |
5.193279 |
- |
BRCA1_00623 |
5 |
c.181T>G |
300T>G |
p.C61G |
0.9998 |
5 - Definitely pathogenic |
Spearman et al. 2008 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
- |
8.703 |
147.7 |
- |
- |
1285.43 |
- |
BRCA1_00099 |
5 |
c.191G>A |
310G>A |
p.C64Y |
1 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
5300394.003 |
189.0906459 |
- |
- |
- |
1002254926 |
- |
BRCA1_00629 |
5 |
c.199G>T |
318G>T |
p.D67Y |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.01 |
0.00 |
0.03 |
0.0832 |
- |
0.00059 |
1.91 |
- |
9.37581E-5 |
- |
BRCA1_00052 |
5 |
c.203T>A |
322T>A |
p.I68K |
0.822262834 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
- |
- |
2.306897919 |
1.033092037 |
- |
2.383237871 |
- |
BRCA1_00282 |
5 |
c.211A>G |
330A>G |
p.R71G |
0.99938835 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
0.34 |
0.02 |
0.81 |
383.2655792 |
- |
- |
- |
- |
383.2655792 |
- |
BRCA1_00288 |
5 |
c.212G>A |
331G>A |
p.R71K |
- |
- |
Parsons et al 2019 |
- |
0.29 |
0.97 |
0.02 |
0.97 |
1.9779 |
- |
- |
- |
- |
1.9779 |
- |
BRCA1_00207 |
5 |
c.212+1G>A |
IVS5+1G>A |
- |
0.999995379 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1794.175683 |
3.73 |
- |
- |
- |
6692.275297 |
- |
BRCA1_00309 |
5 |
c.212+1G>T |
IVS5+1G>T |
- |
0.998791316 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
7.649524872 |
3.3410048 |
- |
- |
- |
25.55709932 |
- |
BRCA1_00321 |
5 |
c.212+3A>G |
IVS5+3A>G |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
1.10E+03 |
1.32 |
- |
1.45E+03 |
- |
BRCA1_00134 |
5 |
c.212+21G>A |
IVS5+21G>A |
- |
0.050387597 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
2.6 |
- |
- |
- |
2.6 |
- |
BRCA1_00290 |
5 |
c.212+29G>A |
IVS5+29G>A |
- |
0.008097166 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.4 |
- |
- |
- |
0.4 |
- |
BRCA1_00291 |
5 |
c.213-12A>G |
IVS5-12A>G |
- |
0.999999999 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
29429.37873 |
1132.138382 |
- |
- |
- |
33318129.21 |
- |
BRCA1_00323 |
6 |
c.216C>A |
335C>A |
p.S72R |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
1.27958483 |
1.067279157 |
- |
1.365674219 |
- |
BRCA1_00296 |
6 |
c.230C>T |
349C>T |
p.T77R |
0.895792298 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.3 |
- |
16.4493 |
1.10591011 |
1.102597599 |
- |
20.05784597 |
- |
BRCA1_00637 |
6 |
c.230_238del |
349delCGAGATTTA |
p.T77_F79del |
0.983204312 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.66 |
1.8333 |
16.4493 |
- |
- |
- |
30.15650169 |
- |
BRCA1_00308 |
6 |
c.259T>G |
378T>G |
p.L87V |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
1.359138616 |
1.067279157 |
- |
1.450580317 |
- |
BRCA1_00328 |
6 |
c.267C>G |
386C>G |
p.I89M |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.914806725 |
1.176779436 |
- |
1.076525742 |
- |
BRCA1_00335 |
6 |
c.301+6T>C |
IVS6+6T>C |
- |
0.001 |
2 - Likely not pathogenic or of little clinical significance |
Thomassen et al. 2012 |
Vallee et al. 2016 |
- |
0.34 |
0.00 |
0.34 |
2.00E-03 |
- |
- |
1.06 |
- |
2.12E-03 |
- |
BRCA1_00148 |
6 |
c.301+7G>A |
IVS6+7G>A |
- |
9.89343E-13 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
1.363440054 |
0.001087452 |
0.037415892 |
0.068385089 |
1.27785E-05 |
4.84778e-11 |
- |
BRCA1_00653 |
6 |
c.301+8T>C |
IVS6+8T>C |
- |
0.00425963 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.120519844 |
1.739254919 |
- |
0.209614732 |
- |
BRCA1_00362 |
6 |
c.301+10G>A |
IVS6+10G>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
1.455675089 |
1.033092037 |
- |
1.503846343 |
- |
BRCA1_00358 |
6 |
c.301+26A>C |
IVS6+26A>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
3.7199 |
0.4 |
- |
- |
- |
1.48796 |
- |
BRCA1_00359 |
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
6 |
c.301+27C>A |
IVS6+26C>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
1.8818 |
- |
- |
- |
- |
1.8818 |
- |
BRCA1_00360 |
6 |
c.302-2del |
IVS6-2delA |
- |
0.999999999 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
58263.43937 |
387.6735235 |
1.870300597 |
1.430636021 |
- |
60436990.13 |
- |
BRCA1_00327 |
6 |
c.302-1G>C |
IVS6-1G>C |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
1 |
69.25 |
1.03 |
- |
71.33 |
- |
BRCA1_00121 |
7 |
c.302-3C>G |
IVS6-3C>G |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
190.55 |
1.17 |
- |
223.87 |
- |
BRCA1_00120 |
7 |
c.305C>G |
424C>G |
p.A102G |
0.000723806 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.030160451 |
1.176779436 |
- |
0.035492198 |
- |
BRCA1_00367 |
7 |
c.314A>G |
433A>G |
p.Y105C |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1.32 |
- |
0.148 |
0.00003 |
- |
5.86080E-6 |
- |
BRCA1_00053 |
7 |
c.332A>C |
451A>C |
p.E111A |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.641810162 |
1.033092037 |
- |
0.663048968 |
- |
BRCA1_00384 |
7 |
c.347A>G |
466A>G |
p.E116G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.318751854 |
1.033092037 |
- |
1.362392039 |
- |
BRCA1_00395 |
7 |
c.370A>G |
489A>G |
p.I124V |
0.00014 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.00617 |
1.1 |
- |
0.00679 |
- |
BRCA1_00054 |
7 |
c.380G>A (Reported 2 times) |
499G>A |
p.S127N |
0.1645 |
3 - Uncertain |
Spearman et al. 2008 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
9.65 |
- |
- |
9.65 |
- |
BRCA1_00103 |
7 |
c.396C>A |
515C>A |
p.N132K |
0.00017 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
0.00479 |
1.698 |
- |
0.00813 |
- |
BRCA1_00119 |
7 |
c.397C>T |
516C>T |
p.R133G |
3.11854E-07 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.0001 |
0.4 |
0.357939218 |
1.067279157 |
- |
0.0000152808 |
- |
BRCA1_00425 |
7 |
c.398G>A |
517G>A |
p.R133H |
0.002724453 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.117517927 |
1.1390848 |
- |
0.133862884 |
- |
BRCA1_00427 |
7 |
c.425C>A |
544C>A |
p.P142H |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Chenevix-Trench et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1.7 |
0.0069 |
- |
0.0043 |
- |
5.04390E-5 |
- |
BRCA1_00025 |
7 |
c.427G>A |
546G>A |
p.E143K |
0.00001 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.0813 |
- |
0.00501 |
1.32 |
- |
0.00054 |
- |
BRCA1_00055 |
7 |
c.429A>C |
548A>C |
p.E143D |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
1.36 |
- |
- |
- |
1.36 |
- |
BRCA1_00686 |
7 |
c.441+2T>A |
IVS7+2T>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
- |
1.048 |
- |
1.048 |
- |
BRCA1_00382 |
8 |
c.442C>T |
561C>T |
p.Q148E |
- |
- |
Parsons et al 2019 |
- |
0.99 |
0.34 |
0.02 |
0.99 |
- |
- |
0.64538081 |
1.067279157 |
- |
0.688801487 |
- |
BRCA1_00478 |
8 |
c.455T>C |
574T>C |
p.L152P |
0.005104767 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.22802243 |
1.102597599 |
- |
0.251416984 |
- |
BRCA1_00492 |
8 |
c.463C>G |
582C>G |
p.Q155E |
0.00004 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.537 |
0.00355 |
- |
0.00191 |
- |
BRCA1_00056 |
8 |
c.469T>C |
588T>C |
p.S157P |
0.008291213 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.383841549 |
1.067279157 |
- |
0.409666085 |
- |
BRCA1_00506 |
8 |
c.478G>C |
597G>C |
p.G160R |
0.002342184 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.111351606 |
1.033092037 |
- |
0.115036457 |
- |
BRCA1_00516 |
8 |
c.484G>T |
603G>T |
p.V162M |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.237584127 |
1.067279157 |
- |
1.320847744 |
- |
BRCA1_00520 |
8 |
c.508C>T |
627C>T |
p.R170G |
0.000758678 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.544 |
0.064077593 |
1.067279157 |
- |
0.037203442 |
- |
BRCA1_00540 |
8 |
c.509G>A |
628G>A |
p.R170Q |
0.145805876 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.896600838 |
4.41 |
- |
- |
- |
8.364009697 |
- |
BRCA1_00543 |